Director, HCP Marketing - DM1

About this role

Company Overview:

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Role Summary:

The Director, HCP Marketing - DM1, leads the development and execution of HCP-focused strategies and initiatives that empower care providers who treat Myotonic Dystrophy. In an active launch environment, this role is pivotal in driving impactful HCP engagement programs that support successful market entry and long-term adoption. It blends strategic vision with hands-on execution, ensuring Dyne delivers meaningful engagement and education aligned with our mission and brand objectives. You operate with agility to meet critical launch milestones, leverage innovative technologies and omnichannel tactics to maximize educational objectives. Collaboration across Marketing, Medical Affairs, Scientific Affairs, Market Access, and Field Teams is essential to create a cohesive HCP experience from awareness through treatment, while continuously optimizing based on real time insights and launch KPIs.

This role is based in Waltham, MA.

Primary Responsibilities:

HCP Strategy & Launch Execution (in alignment with Brand Strategy)